<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03971630</url>
  </required_header>
  <id_info>
    <org_study_id>MyVENT1</org_study_id>
    <nct_id>NCT03971630</nct_id>
  </id_info>
  <brief_title>Tele-monitoring of Patients With Home Mechanical Ventilation (HMV) Trough Telemedicine System (MyVENT)</brief_title>
  <acronym>MyVENT</acronym>
  <official_title>Tele-monitoring of Patients With Home Mechanical Ventilation. &quot;MyVENT&quot; Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eurecat</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sociedad Española de Neumología y Cirugía Torácica</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve HMV treatment adherence using an integrated
      telemedicine platform (MyVENT system)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose a study to evaluate the effect of using tele-monitoring in the
      follow-up of patients with HMV in order to improve their compliance and evaluate its
      cost-effectiveness. Telemedicine will be provided by an integrated platform composed by a
      website and a smartphone application for achieve a real feedback between patients and
      clinicians.

      Design: Prospective randomized clinical study that will include 184 patients with HMV. The
      study will be divided in two phases, the first one consisting on the website and App system
      development and the second one consisting on a clinical trial where the two follow-up systems
      (standard care vs MyVENT group) will be compared.

      Randomization: Patients will be randomised into two groups, HMV treatment management with
      standard care vs. telemedicine follow up.

      Intervention:

      Group 1:MyVENT group: patients will be followed up by tele-monitoring support. MyVENT System
      will be updated with data extracted from the ventilation equipment. This information and the
      results of the complementary tests will be sent to the clinician.

      Moreover, with MyVENT APP patients will receive information about their treatment and advices
      to improve therapy if needed.

      Group 2: Standard care. In this group all the visits will be performed at hospital following
      daily clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to HMV treatment.</measure>
    <time_frame>9 months</time_frame>
    <description>The number of treatment hours will be obtained by the system counter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment efficiency</measure>
    <time_frame>9 months</time_frame>
    <description>Reduce or maintain carbon dioxide (CO2) in the measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>9 months</time_frame>
    <description>In both arms the evaluation of the cost effectiveness will be made at the end of the study in each group including: (telemedicine cost, HMV carrying charge, number of visits and calls).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early detection of problems</measure>
    <time_frame>9 months</time_frame>
    <description>In MyVENT group the system will send notices to the clinician if it detects any problem in order to solve problems earlier.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Define the patient satisfaction</measure>
    <time_frame>9 months</time_frame>
    <description>The study will evaluate the experience of the patient in both follow-up models they will be asked about their satisfaction grade with the follow up care provided during the study using a questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Ventilatory Failure</condition>
  <arm_group>
    <arm_group_label>Standard care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>These patients will be followed by standard protocol in the Unit of HMV of the University Hospital of Santa María- University Hospital Arnau de Vilanova.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MyVENT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients will be followed up using the telemedicine (MyVENT System and APP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine</intervention_name>
    <description>Patients will be followed up using the MyVENT System and APP</description>
    <arm_group_label>MyVENT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women over to 18 years old.

          -  Signed informed consent.

          -  Good knowledge about the use of smartphones.

          -  Patients with Chronic Obstructive Pulmonary Disease (COPD), obesity-hypoventilation
             syndrome and chest wall disorders who had started HMV at least three months before
             their inclusion.

        Exclusion Criteria:

          -  Chronic pathology limiting life expectancy less than 1 year.

          -  Psychiatric limiting problems.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ferran Barbe Illa, MD</last_name>
    <phone>+34 (973) 70 53 72</phone>
    <email>fbarbe.lleida.ics@gencat.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Ferran Barbe Illa, MD</last_name>
      <email>fbarbe.lleida.ics@gencat.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2019</study_first_posted>
  <last_update_submitted>May 31, 2019</last_update_submitted>
  <last_update_submitted_qc>May 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HMV</keyword>
  <keyword>Tele-monitoring</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Chronic hypercapnic respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

